REFERENCES
- Siegel R, Naishadham D, and Jemal A: Cancer statistics. CA Cancer J Clin 62, 10–29, 2012.
- Sargent D, Sobrero A, Grothey A, O’Connell MJ, Buyse M, et al.: Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27, 872–877, 2009.
- Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, et al.: Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109, 820–831, 2007.
- Sonis ST: Pathobiology of mucositis. Semin Oncol Nurs 20, 11–15, 2004.
- Zhu DJ, Chen XW, Wu JH, Ju YL, Feng J, et al.: Effect of perioperative intestinal probiotics on intestinal flora and immune function in patients with colorectal cancer (abstr). Nan Fang Yi Ke Da Xue Xue Bao 32, 1190–1193, 2012.
- Howarth GS and Wang H: Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients 5, 58–81, 2013.
- Howarth GS: Probiotic-derived factors: probiotaceuticals? J Nutr 140, 229–230, 2010.
- Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, et al.: World gastroenterology organisation global guidelines: probiotics and prebiotics october 2011. J Clin Gastroenterol 46, 468–481, 2012.
- Matthes H, Krummenerl T, Giensch M, Wolff C, and Schulze J: Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med 10, 13, 2010.
- Dylag K, Hubalewska-Mazgaj M, Surmiak M, Szmyd J, and Brzozowski T: Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Curr Pharm Des 20, 1149–1155, 2014.
- Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, et al.: Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE 2, e1308, 2007.
- Prisciandaro LD, Geier MS, Chua AE, Butler RN, Cummins AG, et al.: Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage. Support Care Cancer 1–6, 2012.
- Prisciandaro LD, Geier MS, Butler RN, Cummins AG, and Howarth GS: Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats. Cancer Biology and Therapy 11, 671–677, 2011.
- Talarico TL and Dobrogosz WJ: Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother 33, 674–679, 1989.
- Wang Y, Kirpich I, Liu Y, Ma Z, Barve S, et al.: Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol 179, 2866–2875, 2011.
- Yan F, Cao H, Cover TL, Whitehead R, Washington MK, et al.: Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562–575, 2007.
- Bar F, Von Koschitzky H, Roblick U, Bruch HP, Schulze L, et al.: Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterol Motil 21, 559–566, 2009.
- Otte JM, Mahjurian-Namari R, Brand S, Werner I, Schmidt WE, et al.: Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr Cancer 61, 103–113, 2009.
- Nurmi JT, Puolakkainen PA, and Rautonen NE: Bifidobacterium Lactis sp. 420 up-regulates cyclooxygenase (Cox)-1 and down-regulates Cox-2 gene expression in a Caco-2 cell culture model. Nutr Cancer 51, 83–92, 2005.
- Cousin FJ, Jouan-Lanhouet S, Dimanche-Boitrel MT, Corcos L, and Jan G: Milk fermented by Propionibacterium freudenreichii induces apoptosis of HGT-1 human gastric cancer cells. PLoS ONE 7, e31892, 2012.
- Araki Y, Andoh A, Fujiyama Y, Takizawa J, Takizawa W, et al.: Oral administration of a product derived from Clostridium butyricum in rats. Int J Mol Med 9, 53–57, 2002.
- Derzelle S, Bolotin A, Mistou MY, and Rul F: Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein. Appl Environ Microbiol 71, 8597–8605, 2005.
- Shen Z, Hou N, Jin M, Qiu Z, Wang J, et al.: A novel enzyme-linked immunosorbent assay for detection of Escherichia coli O157:H7 using immunomagnetic and beacon gold nanoparticles. Gut Pathog 6, 14, 2014.
- Huynh-Delerme C, Huet H, Noel L, Frigieri A, and Kolf-Clauw M: Increased functional expression of P-glycoprotein in Caco-2 TC7 cells exposed long-term to cadmium. Toxicol In Vitro 19, 439–447, 2005.
- Cheah KY: Grape Sourced Bioactives: A Potential New Treatment Strategy FOR Intestinal Mucositis and Colon Cancer. Adelaide, Australia: The University of Adelaide Press, 2012.
- Fauser JK: Medium Chain Fatty Acids and Wnt/β-Catenin Inhibitors as Adjunctive Colorectal Cancer Chemotherapeutic Agents. Adelaide, Australia: The University of Adelaide Press, 2013.
- Cheah KY, Howarth GS, Yazbeck R, Wright TH, Whitford EJ, et al.: Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. Cancer Biol Ther 8, 382–390, 2009.
- Benzie IF and Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239, 70–76, 1996.
- Benson AB, III, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, et al.: Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 11, 519–528, 2013.
- Keefe DM, Sonis ST, and Bowen JM: Emerging drugs for chemotherapy-induced mucositis. Expert Opin Emerg Drugs 13, 511–522, 2008.
- OXOID: Dehydrated Culture Media: Modified Tryptone Soya Broth. Accessed from http://www.oxoid.com/UK/blue/prod_detail/prod_detail.asp?pr=CM0989&sec=2&org=72&c=UK&lang=EN
- Li N and Neu J: Glutamine deprivation alters intestinal tight junctions via a PI3-K/Akt mediated pathway in Caco-2 cells. J Nutr 139, 710–714, 2009.
- Tuhacek LM, Mackey AD, Li N, DeMarco VG, Stevens G, et al.: Substitutes for glutamine in proliferation of rat intestinal epithelial cells. Nutrition 20, 292–297, 2004.
- Gibco®: LB Broth (Liquid). Accessed from http://www.lifetechnologies.com/order/catalog/product/10855001.
- Sezonov G, Joseleau-Petit D, and D’Ari R: Escherichia coli physiology in Luria-Bertani broth. J Bacteriol 189, 8746–8749, 2007.
- Wang CH and Koch AL: Constancy of growth on simple and complex media. J Bacteriol 136, 969–975, 1978.
- Wee S and Wilkinson BJ: Increased outer membrane ornithine-containing lipid and lysozyme penetrability of Paracoccus denitrificans grown in a complex medium deficient in divalent cations. J Bacteriol 170, 3283–3286, 1988.
- Nikaido H: The Limitations of LB Medium. Accessed from http://schaechter.asmblog.org/schaechter/2009/11/the-limitations-of-lb-medium.html
- OXOID: Dehydrated Culture Media: MRS Broth. Accessed from http://www.oxoid.com/UK/blue/prod_detail/prod_detail.asp?pr=CM0359&c=UK&lang=EN
- Ahmed N and Furth AJ: Failure of common glycation assays to detect glycation by fructose. Clin Chem 38, 1301–1303, 1992.
- Yun SP, Lee SJ, Jung YH, and Han HJ: Galectin-1 stimulates motility of human umbilical cord blood-derived mesenchymal stem cells by downregulation of smad2/3-dependent collagen 3/5 and upregulation of NF-kappaB-dependent fibronectin/laminin 5 expression. Cell Death Dis 5, e1049, 2014.
- Prisciandaro LD: The Use of Probiotic-Derived Factors in the Treatment and Prevention of 5-Fluorouracil-Induced Intestinal Mucositis. Adelaide, Australia: The University of Adelaide Press, 2012.
- Wang H, Bastian SE, Cheah KY, Lawrence A, and Howarth GS: Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage. Cancer Biol Ther 15, 560–569, 2014.
- Silva DG, Belini Junior E, de Almeida EA, and Bonini-Domingos CR: Oxidative stress in sickle cell disease: an overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies. Free Radic Biol Med 65, 1101–1109, 2013.
- Zidek Z, Kmonickova E, Kostecka P, and Tlaskalova-Hogenova H: Decisive role of lipopolysaccharide in activating nitric oxide and cytokine production by the probiotic Escherichia coli strain Nissle 1917. Folia Microbiol (Praha) 55, 181–189, 2010.
- Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, et al.: Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 3, 203–213, 2001.
- Stetinova V, Smetanova L, Kvetina J, Svoboda Z, Zidek Z, et al.: Caco-2 cell monolayer integrity and effect of probiotic Escherichia coli Nissle 1917 components. Neuro Endocrinology Letters 31(Suppl. 2), 51–56, 2010.
- Pan X, Zhang X, Sun H, Zhang J, Yan M, et al.: Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells. PLoS ONE 8, e56679, 2013.
- Seth A, Yan F, Polk DB, and Rao RK: Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 294, G1060–1069, 2008.